FINANCIALS

FOLD Amicus Therapeutics Inc 1178879

Income Statement
Revenue	fold-20240930	141,517,000
Net Income	fold-20240930	-6,729,000
Profit Margin		-4.75%

Balance Sheet
Current Assets	498,474,000
Assets	786,557,000
Current Liabilities	158,138,000
Liabilities	607,732,000
Equity	178,825,000
Shares Out	296,591,000

Cash Flow Statement
Operating Cash Flow	-29,975,000
Investing Cash Flow	19,832,000

Market Analysis
Market Cap	3,341,096,590
Price	9.41
BVPS	0.60
PB	15.61
EPS	-0.40
PS	5.90
FCF	-10,143,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view FOLD documents filed with the SEC.

FOLD Filings Clear

View A List of Tickers